Orbis Research has announced the addition of the Electrophysiology Market by company, by country, and by application/type for the competitive landscape analysis.
Electrophysiology (EP) is the branch of science that deals with the study of electric activity in the human body. EP devices are used to treat abnormal electrical properties of cell and tissues that leads to various cardiac arrhythmias. Innovative EP technologies are developed to improve the diagnosis and treatment of life-threatening conditions, such as atrial fibrillation (AF), atrial flutter, Wolff-Parkinson-White Syndrome (WPW), atrioventricular nodal reentry tachycardia (AVNRT), and other cardiac arrhythmias.
The growing incidence of AF-one of the most common heart rhythm disorder or arrhythmia is the prime factor to drive the growth of the EP market. In addition, cardiovascular diseases treatment market is assured to grow on account of unmet clinical needs and upcoming treatment modifications. Increase in baby boomer generation with high-risk of targeted diseases and increase in adoption of EP catheter ablation propels the market growth.
Moreover, rise in focus of the key players toward innovative EP technologies (such as 3D mapping systems, novel diagnostic catheters, and laser ablation systems), has fuel the demand for EP devices across various settings in EP labs. However, stringent government regulations, high cost of the advanced EP devices, preference to pharmaceutical interventions (drugs) over EP treatment devices and dearth of skilled & experienced electrophysiologists are set to restrain the market growth. The world electrophysiology market is projected reach $8,271 Million by 2022, growing at a CAGR of 13.4% during 2016 to 2022, from 2015 market value of $3,420 million.
The world electrophysiology market is segmented on the basis of product, indication and geography. Based on product, the market is segmented primarily into EP ablation catheters, EP laboratory devices, EP diagnostic catheters, access devices and others. EP ablation catheter is further sub-segmented into cryoablation EP catheters, radiofrequency EP catheters, microwave EP catheters, laser EP catheters, and navigational advanced mapping accessories. Radiofrequency EP catheters are further categorized into conventional and irrigated-tip ablation catheters. Radiofrequency EP catheters has the largest market share, owing to high prevalence rate of atrial fibrillation and technological advancements in RF ablation such as irrigated tip catheters, which is found to be superior (in terms of efficacy and safety) than conventional RF ablation. Cryoablation EP catheter market is expected to grow at the fastest rate due to technological advancements in this sector and preferred option by the physicians to ablate abnormal cardiac cells, where procedural precision is crucial. In addition, EP X-Ray Systems holds remarkable share in the EP market and poised to grow at steady pace due to the growing demand in EP labs to enhance the ability to perform complex procedures with confidence. Moreover, steerable diagnostic catheters are the driving force behind the growth of conventional EP diagnostic catheters attributed to the rising adoption of these devices gaining FDA approval for the treatment of AF. Based on indication, the market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), Wolff-Parkinson-white syndrome (WPW) and others. Atrial fibrillation holds the highest share in the indication segment owing to the high incident rate and the most common type of cardiac arrhythmia in clinical practice.
Place a direct purchase order on this report at http://www.orbisresearch.com/contact/purchase/222385 . AND if you have enquire before buying this report visit at http://www.orbisresearch.com/contacts/enquiry-before-buying/222385 .
The geographical segmentation of the market includes North America, Europe, Asia-Pacific, and LAMEA. In 2015, North America accounted for the largest market share of 36.2% in the EP market and estimated to retain its dominant position throughout the forecast period. The growth in this region is mainly due to the factors such as product innovations, sophisticated healthcare infrastructure, U.S. – being the target area for the top players in the market owing to high prevalence rate of AF. Nevertheless, Asia Pacific region is expected to emerge as the area with maximum growth potential due to the rising number of cardiovascular diseases, presence of high unmet needs, and increased focus of key players towards emerging markets such as China and India, and increased healthcare spending for the development of improved healthcare infrastructure.
Request a sample for this report @ http://www.orbisresearch.com/contacts/request-sample/222385 .
1 Abbott Laboratories
1.1 Company overview
1.2 Company snapshot
1.3 Operating business segments
1.4 Business performance
1.5 Key strategic moves and developments
2 Johnson & Johnson
2.1 Company overview
2.2 Company snapshot
2.3 Operating business segments
2.4 Business performance
2.5 Key strategic moves and developments
3 Microport Scientific Corporation
3.1 Company overview
3.2 Company snapshot
3.3 Operating business segments
3.4 Business performance
3.5 Key strategic moves and developments
4 Boston Scientific Corporation
4.1 Company overview
4.2 Operating business segments
4.3 Business performance
4.4 Key strategic moves and developments
5 St. Jude Medical, Inc.
5.1 Company overview
5.2 Company snapshot
5.3 Operating business segments
5.4 Business performance
5.5 Key strategic moves and developments
6 Medtronic plc
6.1 Company overview
6.2 Company snapshot
6.3 Operating business segments
6.4 Business performance
6.5 Key strategic moves and developments
7 Biotronik SE & Co. KG
7.1 Company overview
7.2 Company snapshot
7.3 Operating business segments
7.4 Key strategic moves and developments
8 Koninklijke Philips N.V.
8.1 Company overview
8.2 Company snapshot
8.3 Operating business segments
8.4 Business performance
8.5 Key strategic moves and developments
9 General Electric Co.
9.1 Company overview
9.2 Company snapshot
9.3 Operating business segments overview
9.4 Business performance
9.5 Key strategic moves and developments
10 Siemens AG
10.1 Company overview
10.2 Company snapshot
10.3 Operating business segments
10.4 Financial performance
10.5 Key strategic moves and developments
Product development and launch is the mostly adopted strategy in the electrophysiology market followed by acquisition. The report provides a comprehensive analysis of the key players that operate in the world Electrophysiology market such as:
St. Jude Medical, Inc.
Boston Scientific Corporation,
Biosense Webster, Inc. (a Johnson & Johnson Company)
GE Healthcare (a division of General Electric Company.)
Philips Healthcare (a division of Koninklijke Philips N.V.)
Biotronik SE & Co.KG
Microport Scientific Corporation
KEY MARKET BENEFITS
The study provides an in-depth analysis of the world electrophysiology market with current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of the market, by product, helps understand various types of devices used for the treatment of atrial fibrillation, atrial flutter, Wolff-Parkinson-White Syndrome, atrioventricular nodal reentry tachycardia, and other cardiac arrhythmias.
Competitive intelligence highlights the business practices followed by the leading market players across various geographies.
Porter’s Five Forces model will interpret the bargaining power of suppliers and buyers, threat of new entrants and substitutes, and competition amongst the key players.
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: email@example.com
Follow Us on Linkedin: https://www.linkedin.com/company/orbis-research